Exploring cannabidiol, cortisol, the endocannabinoid system, terpenes and the scientific evidence concerning stress responses.
Stress is a natural part of life. It helps the body respond to challenges, adapt to changing circumstances and maintain biological stability. However, when stress becomes persistent, it can affect sleep, mood, concentration, immune function and overall wellbeing.
Researchers have increasingly investigated cannabidiol (CBD) and its interactions with biological systems involved in stress regulation.
Several studies have identified potentially important mechanisms, while human clinical trials have produced both encouraging and inconclusive findings.
Understanding this research requires distinguishing the body's natural stress responses from chronic psychological stress, as well as distinguishing purified CBD from full-spectrum hemp extracts.
What Is Full-Spectrum CBD?
Full-spectrum CBD is a cannabis-derived extract containing cannabidiol alongside other naturally occurring plant constituents.
Depending on its composition, a full-spectrum extract may contain:
Minor cannabinoids, including cannabigerol (CBG) and cannabichromene (CBC).
Terpenes, including myrcene, limonene and linalool.
Flavonoids and other plant compounds.
Varying concentrations of tetrahydrocannabinol (THC), where present.
This differs from CBD isolate, which consists predominantly of purified cannabidiol.
Scientists have investigated whether these compounds interact in ways that modify their individual biological effects.
Such interactions are often described using the term entourage effect.
Although research has identified several potentially important interactions, the clinical advantages of full-spectrum CBD over purified CBD remain insufficiently established for stress-related outcomes. [5]
Understanding the Biological Stress Response
Stress engages several interconnected systems within the body.
One of the most important is the hypothalamic–pituitary–adrenal (HPA) axis.
When the brain detects a challenge, the HPA axis coordinates hormonal responses involving the hypothalamus, pituitary gland and adrenal glands.
This process influences the secretion of cortisol, a glucocorticoid hormone involved in energy metabolism, immune regulation and adaptation to stress.
Cortisol is not inherently harmful. Its concentration varies naturally throughout the day, and temporary increases are important components of normal physiology.
Problems can arise when the regulation of stress responses becomes persistently disrupted.
Research into CBD has explored whether cannabinoid signalling influences these systems.
The Endocannabinoid System and Stress Regulation
The endocannabinoid system (ECS) is a biological signalling network involving naturally occurring endocannabinoids, cannabinoid receptors and enzymes responsible for producing and degrading signalling molecules.
Two well-studied cannabinoid receptors are CB1 and CB2.
CB1 receptors are particularly important in the central nervous system, while CB2 receptors are associated with several immune and peripheral signalling processes.
Research indicates that endocannabinoid signalling participates in the regulation of stress-related behaviour and the HPA axis.
Hill and colleagues demonstrated that endogenous cannabinoid signalling plays an important role in adaptation to repeated stress in a preclinical experimental model. [1]
These findings provide a biological foundation for further investigation.
However, demonstrating the importance of the body's natural cannabinoid system does not automatically establish that administering CBD will reproduce those effects in humans.
CBD has complex pharmacological actions and does not simply activate CB1 and CB2 receptors in the same way as the body's own endocannabinoids.
CBD and Cortisol: What Does the Research Show?
One of the most frequently discussed questions is whether CBD influences cortisol concentrations.
The evidence is more nuanced than a simple claim that CBD lowers cortisol.
Early Human Research
In 1993, Zuardi and colleagues investigated the effects of CBD on several hormones, including cortisol, in 11 healthy volunteers.
Participants received CBD or placebo during controlled experimental sessions.
The researchers observed that cortisol concentrations declined naturally during the placebo sessions, consistent with the hormone's normal daily rhythm.
CBD significantly attenuated this decline.
The researchers concluded that CBD could influence cortisol secretion. [2]
This study provides evidence of an interaction between CBD and endocrine regulation, but it does not establish that CBD consistently reduces cortisol.
CBD During Experimental Stress
A 2020 study by Appiah-Kusi and colleagues examined CBD's influence on stress responses in people considered at clinical high risk of developing psychosis.
Thirty-two patients and 26 healthy controls participated in an experimental social stress procedure.
Half of the patient group received 600 mg of CBD daily for one week, while the other half received placebo.
Researchers assessed cortisol responses and psychological reactions to the stressful task.
The CBD-treated group showed an intermediate pattern of response, but the difference in cortisol reactivity between the CBD-treated and placebo-treated patient groups was not statistically significant. [3]
The authors recommended larger studies to investigate these findings.
Together, these experiments demonstrate that CBD's relationship with cortisol regulation is scientifically interesting but not yet sufficiently established to support general claims of cortisol reduction.
Can Full-Spectrum CBD Reduce Perceived Stress?
An important distinction exists between biological stress markers, such as cortisol, and a person's subjective experience of stress.
Clinical studies often measure these outcomes separately.
A randomised controlled trial published in 2025 investigated low-dose full-spectrum CBD oil in 180 highly stressed university students considered at risk for depression.
Participants were assigned to CBD oil, placebo oil or a no-treatment control group over approximately one month.
The investigators examined perceived stress and psychological distress.
Although participants reported improvements over time, the study did not identify a specific benefit of CBD over placebo for the principal stress and psychological-distress outcomes. [4]
The findings highlight the importance of placebo-controlled research.
They also demonstrate why improvements reported by individuals cannot automatically be attributed to the pharmacological effects of CBD.
The results apply to the tested preparation, dosing schedule and participant population. They do not establish that every CBD formulation will produce identical outcomes.
The Entourage Effect and Stress
Full-spectrum extracts contain additional cannabinoids and terpenes that may influence biological activity.
Terpenes such as linalool, myrcene and limonene have attracted attention for their pharmacological properties.
Researchers have investigated interactions between these compounds and cannabinoids, including whether combinations might alter effects observed with individual substances.
A comprehensive 2024 review examined research into cannabinoid and terpene interactions. [5]
The review described mechanistic and experimental evidence supporting further investigation while highlighting the need for more rigorous clinical studies.
The central scientific question is whether specific combinations produce measurable effects beyond those expected from their individual constituents.
This remains an active research area.
The presence of multiple plant compounds in a full-spectrum extract does not, by itself, establish superior stress reduction.
CBD, Stress and Sleep
Stress and sleep are closely connected.
Persistent psychological stress may interfere with sleep onset, sleep continuity and perceived sleep quality. Poor sleep can subsequently increase sensitivity to stressful experiences.
Researchers have investigated whether CBD or combinations of cannabinoids and terpenes influence sleep.
Research Using Purified CBD
A 2024 randomised pilot trial investigated nightly administration of 150 mg of CBD in 30 adults with moderate-to-severe insomnia.
The study reported some improvements in selected measures, but CBD did not significantly improve insomnia severity or several other sleep outcomes compared with placebo. [6]
Research Using CBD and Terpenes
Another 2024 randomised crossover trial investigated a formulation containing 300 mg of CBD combined with eight terpenes in 125 adults with insomnia.
The treatment produced a small increase in the proportion of sleep spent in slow-wave and REM stages compared with placebo.
However, it did not increase total sleep time. [7]
Importantly, the study used a defined CBD-terpene combination rather than a typical whole-plant full-spectrum extract.
It also did not determine whether the observed effects resulted from CBD, individual terpenes or their interactions.
These results support further investigation but cannot establish that all full-spectrum CBD products reliably improve sleep.
CBD, Inflammation and Physical Stress Responses
Psychological stress, immune signalling and inflammatory processes are interconnected.
The endocannabinoid system participates in several aspects of immune regulation, and cannabinoid compounds have been investigated for their effects on inflammatory pathways.
Experimental research has identified possible anti-inflammatory mechanisms involving CBD.
However, effects observed in isolated cells or animal models do not necessarily translate into clinically meaningful improvements in humans.
Nor does demonstrating an anti-inflammatory effect automatically establish that a substance reduces the physical consequences of chronic psychological stress.
Further human studies are needed to clarify these relationships.
Understanding the Safety of CBD
Purified CBD has generally demonstrated relatively low abuse potential.
However, this does not mean that CBD-containing products are free of risks.
Documented safety considerations include:
Potential interactions with prescription medications.
Changes in liver enzyme concentrations, particularly at some therapeutic doses.
Adverse effects that vary with dosage and individual circumstances.
Additional considerations when a formulation contains THC.
Differences in composition and purity between preparations.
These factors are important when interpreting clinical studies, particularly when comparing highly purified research formulations with commercially available extracts.
People considering cannabinoid-based approaches to ongoing health concerns should consult an appropriately qualified healthcare professional.
Why Formulation Matters
The term full-spectrum CBD describes a broad category rather than a single standardised substance.
Two products using that description can differ considerably in cannabinoid concentrations, terpene composition and other constituents.
Clinical findings may also depend on:
The specific preparation studied.
The concentrations and proportions of active constituents.
The route of administration.
The duration of treatment.
The health and characteristics of study participants.
The methods used to measure stress-related outcomes.
These details are essential when assessing whether a finding from one study can reasonably be applied to another formulation.
What Does the Evidence Currently Tell Us?
The scientific literature supports several conclusions.
First, the endocannabinoid system is involved in biological stress regulation.
Second, CBD has demonstrated effects on physiological and neurological pathways relevant to stress and anxiety.
Third, some human investigations have reported encouraging findings, while other controlled studies have not demonstrated an advantage over placebo.
Fourth, the clinical effects of full-spectrum preparations depend on their composition and remain incompletely understood.
Finally, existing studies do not establish that CBD consistently lowers cortisol, eliminates stress or provides predictable long-term benefits across different populations.
These limitations do not invalidate the research. They identify the questions that future investigations need to answer.
Stress Less, Understand More
CBD and stress regulation remain active and worthwhile subjects of scientific investigation.
Research into the endocannabinoid system has substantially expanded our understanding of how the body responds and adapts to stressful experiences.
Studies involving CBD have identified intriguing effects on hormonal, neurological and behavioural processes.
At the same time, clinical outcomes remain dependent on the preparation, population and experimental conditions.
Full-spectrum extracts are particularly interesting because they contain multiple biologically active plant constituents whose interactions are still being investigated.
The scientific evidence provides reasons for continued interest, while careful interpretation remains essential.
By examining both the findings and their limitations, we can develop a more accurate understanding of the relationship between cannabinoids and stress physiology.
Scientific References
[1] Hill, M. N., et al. (2010). Endogenous cannabinoid signaling is essential for stress adaptation. Proceedings of the National Academy of Sciences, 107(20), 9406–9411.
https://pubmed.ncbi.nlm.nih.gov/20439721/
[2] Zuardi, A. W., Guimarães, F. S., & Moreira, A. C. (1993). Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Brazilian Journal of Medical and Biological Research, 26(2), 213–217.
https://pubmed.ncbi.nlm.nih.gov/8257923/
[3] Appiah-Kusi, E., et al. (2020). Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis. Psychopharmacology, 237, 1121–1130.
https://doi.org/10.1007/s00213-019-05442-6
[4] Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression. (2025).
https://doi.org/10.1186/s42238-025-00366-9
[5] The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review. (2024). Pharmaceuticals, 17(11), 1543.
https://doi.org/10.3390/ph17111543
[6] Cannabidiol for Moderate–Severe Insomnia: A Randomized Controlled Pilot Trial of 150 mg of Nightly Dosing. (2024). Journal of Clinical Sleep Medicine, 20(5), 753–763.
https://doi.org/10.5664/jcsm.10998
[7] Effects of a Cannabidiol/Terpene Formulation on Sleep in Individuals with Insomnia: A Double-Blind, Placebo-Controlled, Randomized, Crossover Study. (2024). Journal of Clinical Sleep Medicine.
https://doi.org/10.5664/jcsm.11324
This article discusses published scientific research for educational purposes. Clinical findings concerning particular CBD preparations should not be assumed to apply to every full-spectrum hemp extract. The information is not a substitute for professional medical advice.
Join the conversation
Comments
Have a question or something to share? We'd love to hear from you.